Claritin and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported as a side effect among people who take Claritin (loratadine), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Oxycontin, and have Pain.

The phase IV clinical study analyzes which people have Hepatitis c when taking Claritin. It is created by eHealthMe based on reports of 74,516 people who have side effects when taking Claritin from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

What is Hepatitis c?

Hepatitis c is found to be associated with 785 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

On Jul, 21, 2026

74,516 people reported to have side effects when taking Claritin.
Among them, 50 people (0.07%) have Hepatitis c.

Among these 50 people:

How long have people been on Claritin when they have Hepatitis c? *

What is the gender of people who have Hepatitis c when taking Claritin? *

female: 48 %
male: 52 %

What is the age of people who have Hepatitis c when taking Claritin? *

What are other drugs people take besides Claritin? *

What are other side effects people have besides Hepatitis c? *

Chest Pain: 20 people, 40.00%
Confusional State: 18 people, 36.00%
Weakness: 17 people, 34.00%
Headache (pain in head): 17 people, 34.00%
Depression: 15 people, 30.00%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 15 people, 30.00%
Dizziness: 15 people, 30.00%
Hyperkalemia (damage to or disease of the kidney): 14 people, 28.00%
Dehydration (dryness resulting from the removal of water): 14 people, 28.00%
Stress And Anxiety: 14 people, 28.00%

What are the existing conditions these people have? *

Pain: 11 people, 22.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 14.00%
Hypersensitivity: 5 people, 10.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 8.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.00%
Sleep Disorder: 3 people, 6.00%
Bipolar Disorder (mood disorder): 3 people, 6.00%
High Blood Pressure: 3 people, 6.00%
Blood Immunoglobulin G Decreased: 2 people, 4.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and have Hepatitis c?

- Check whether Hepatitis c is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Claritin:

Claritin (77,315 reports)

Hepatitis c treatments and more:

Hepatitis c (131,813 reports)

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis c:

Hepatitis c (785 drugs)

Browse all the conditions that are associated with Hepatitis c:

Hepatitis c (984 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loratadine (the active ingredients of Claritin) and Claritin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.